160
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis

, , , , &
Pages 603-613 | Received 01 Oct 2012, Accepted 09 Jan 2013, Published online: 05 Mar 2013

References

  • Bellis G, Cazes MH, Parant A, et al. Cystic fibrosis mortality trends in France. J Cyst Fibros 2007; 6: 179–186.
  • Girodon E, Cazeneuve C, Lebargy F, et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 1997; 5: 149–155.
  • Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 2002; 19: 575–606.
  • Saiman L. Infection prevention and control in cystic fibrosis. Curr Opin Infect Dis 2011; 24: 390–395.
  • Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010; 137: 171–176.
  • Pihet M, Carrere J, Cimon B, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis – a review. Med Mycol 2009; 47: 387–397.
  • Lebecque P, Leonard A, Huang D, et al. Exophiala (Wangiella) dermatitidis and cystic fibrosis – prevalence and risk factors. Med Mycol 2010; 48 (Suppl. 1): S4–9.
  • Barton RC, Borman AM, Johnson EM, et al. Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis. J Clin Microbiol 2010; 48 (7): 2615–2617.
  • Giraud S, Pihet M, Razafimandimby B, et al. Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis. J Clin Microbiol 2010; 48: 2381–2386.
  • Houbraken J, Spierenburg H, Frisvad JC. Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species. Antonie Van Leeuwenhoek 2012; 101: 403–421.
  • Gilgado F, Cano J, Gené J, Serena C, Guarro J. Different virulence of the species of the Pseudallescheria boydii complex. Med Mycol 2009; 47: 371–374.
  • Lackner M, de Hoog GS, Verweij PE, et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother 2012; 56: 2635–2642.
  • Husain S, Muñoz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40: 89–99.
  • Cimon B, Carrère J, Vinatier J, et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19: 53–56.
  • Blyth CC, Middleton PG, Harun A, et al. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors? Med Mycol 2010; 48(Suppl. 1): S37–44.
  • Heath CH, Slavin MA, Sorrell TC, et al. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect 2009; 15: 689–693.
  • Gilgado F, Cano J, Gené J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43: 4930–4942.
  • Gilgado F, Cano J, Gené J, Sutton D, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008; 46: 766–771.
  • Kaltseis J, Rainer J, De Hoog G. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol 2009; 47: 398–405.
  • Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28: 2731–2739.
  • Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 1993; 10: 512–526.
  • Benzecri JP, Gopolan TK. Correspondence Analysis Handbook, New York: Marcel Dekker, 1991.
  • Escofier B, Pages J. Multiple factor-analysis (AFMULT package). Computational Statistics & Data Analysis 1994; 18: 121–140.
  • Defontaine A, Zouhair R, Cimon B, et al. Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis. J Clin Microbiol 2002; 40: 2108–2114.
  • Lackner M, Rezusta A, Villuendas MC, et al. Infection and colonisation due to Scedosporium in Northern Spain.An in vitro antifungal susceptibility and molecular epidemiology study of60 isolates. Mycoses 2011; 54(Suppl. 3): 12–21.
  • Lu Q, Gerrits van den Ende AH, Bakkers JM, et al. Identification of Pseudallescheria and Scedosporium species by three molecular methods. J Clin Microbiol 2011; 49: 960–967.
  • Harun A, Perdomo H, Gilgado F, et al. Genotyping of Scedosporium species: a review of molecular approaches. Med Mycol 2009; 47: 406–414.
  • Gilgado F, Serena C, Cano J, Gené J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother 2006; 50: 4211–4213.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.